Christopher Michael, MD
Neurosurgery · Dallas, TXNPI 1417978016
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (37.1%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 9 manufacturers reported payments, led by Captiva Spine Inc at 48.6% of the total. Reporting peaked in 2020 at $911 and has fallen 86.4% since, to $124 in 2025.
Across 17 payments — averaging $118.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Captiva Spine Inc$982
- Titan Spine, LLC$625
- Medtronic$116
- Johnson & Johnson$98
- Medical Device Business Services, Inc.$93
- Augmedics Inc.$52
- plus $52 from 3 others
Across 7 payments — averaging $16,910 each. An ownership or investment interest held by the physician or an immediate family member.
- 4web, Inc.$118K
What the payments were for
- Consulting fees$62531%
- Travel & lodging$64432%
- Food & beverage$74937%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Captiva Spine Inc | 4 | $982 |
| Titan Spine, LLC | 1 | $625 |
| Medtronic | 1 | $116 |
| Johnson & Johnson(2 entities) | 4 | $98 |
| Medical Device Business Services, Inc. | 2 | $93 |
| Augmedics Inc. | 2 | $52 |
| Arteriocyte Medical Systems, Inc. | 1 | $18 |
| NX Development Corp. | 1 | $18 |
| AbbVie | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CapLOX II$905
- nanoLOCK$625
- MazorX - Renaissance$116
How this compares
Too few neurosurgery providers in Texasto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 46 | $543 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 13 | $109 |
Paid to pharmacies, not to this prescriber.
Other neurosurgery in Dallas
- Shaad BidiwalaDallas$2K
- Francisco BatlleDallas$664
- Frank FeigenbaumDallas$37
- Shlomo FinnDallas$0
- Gerald MarlinDallas$0
- James EbotDallas$0
- Marco SilvaBeaumont$9K
- Erwin LoBeaumont$8K
- Edward MurphyHouston$2K
- James BonnenWebster$1K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.